UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Journal of Crohn's & colitis, 2014-06, Vol.8 (6), p.443-468

2014

Volltextzugriff (PDF)

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Journal of Crohn's & colitis, 2010-02, Vol.4 (1), p.28-62

2010

Volltextzugriff (PDF)

Serum calprotectin as a biomarker for Crohn's disease

Journal of Crohn's and colitis, 2013-12, Vol.7 (12), p.e678-e683

2013

Volltextzugriff (PDF)

Multilocus Sequence Typing Reveals Intrafamilial Transmission and Microevolutions of Candida albicans Isolates from the Human Digestive Tract

Journal of Clinical Microbiology, 2006-05, Vol.44 (5), p.1810-1820

2006

Volltextzugriff (PDF)

Acute and Chronic Complications After Abdominal/Pelvic Radiation in Patients With Inflammatory Bowel Disease

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E492-E492

2015

Volltextzugriff (PDF)

2114 Chemotherapy tolerance and oncologic outcomes in patients with inflammatory bowel disease and gastrointestinal malignancy: The Mount Sinai Hospital experience

European journal of cancer (1990), 2015-09, Vol.51, p.S367-S368

2015

Volltextzugriff (PDF)

Predictive value of patient-reported outcomes to mucosal healing in patients with moderately to severely active ulcerative colitis

Value in health, 2014-05, Vol.17 (3), p.A40-A40

2014

Volltextzugriff (PDF)

PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)

Value in health, 2011, Vol.14 (7), p.A548-A549

2011

Volltextzugriff (PDF)

PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's Disease

Value in health, 2012-11, Vol.15 (7), p.A332-A333

2012

Volltextzugriff (PDF)

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Journal of Crohn's and colitis, 2009-06, Vol.3 (2), p.47-91

2009

Volltextzugriff (PDF)

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

Journal of Crohn's and colitis, 2013-04, Vol.7 (3), p.213-221

2013

Volltextzugriff (PDF)

European evidence-based Consensus on the management of ulcerative colitis: Current management

Journal of Crohn's and colitis, 2008-03, Vol.2 (1), p.24-62

2008

Volltextzugriff (PDF)

Multiomics Analyses to Deliver the Most Effective Treatment to Every Patient With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2018-11, Vol.155 (5), p.e1-e4

2018

Volltextzugriff (PDF)

Stress-induced disruption of colonic epithelial barrier: role of interferon-γ and myosin light chain kinase in mice

Gastroenterology (New York, N.Y. 1943), 2003-09, Vol.125 (3), p.795-804

2003

Volltextzugriff (PDF)

Preface

Baillière's best practice & research. Clinical gastroenterology, 2003-02, Vol.17 (1), p.1-2

Colombel, J.F.

2003

Volltextzugriff (PDF)

Preface

Baillière's best practice & research. Clinical gastroenterology, 2003-02, Vol.17 (1), p.1

Colombel, J.F

2003

Volltextzugriff (PDF)

P386 Pharmacokinetics of laquinimod in patients with active moderate to severe Crohn's disease

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S226-S226

2014

Volltextzugriff (PDF)

PGI27 - Predictive value of patient-reported outcomes to mucosal healing in patients with moderately to severely active ulcerative colitis

Value in health, 2014-05, Vol.17 (3), p.A40-A40

2014

Volltextzugriff (PDF)

DOP059 Reduction of fecal calprotectin levels and relationship to clinical parameters in the phase 2 study of laquinimod for the treatment of active moderate to severe Crohn's disease

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S43-S43

2014

Volltextzugriff (PDF)

RIP2 polymorphisms in inflammatory bowel diseases

Inflammatory bowel diseases, 2011-04, Vol.17 (4), p.1055-1055

2011

Volltextzugriff (PDF)

Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease

Gut, 2002-01, Vol.50 (1), p.25-28

2002

Volltextzugriff (PDF)

O-10: Increase of inflammatory bowel disease incidence in teenagers in a prospective population-based study during a 21-year period (1998–2008)

Journal of Crohn's and colitis, 2014-09, Vol.8, p.S399-S399

2014

Volltextzugriff (PDF)

DOP028 Development of red flags for early referral of adults with symptoms and signs suggestive of Crohn's disease: an IOIBD initiative

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S28-S28

2014

Volltextzugriff (PDF)

Evidence of Lymphocyte Alveolitis in Crohn's Disease

Chest, 1985-03, Vol.87 (3), p.363-367

1985

Volltextzugriff (PDF)

Familial expression of anti- Saccharomyces cerevisiae mannan antibodies in Crohn’s disease and ulcerative colitis: a GISC study

The American journal of gastroenterology, 2001, Vol.96 (8), p.2407-2412

2001

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(120)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Gastroenterology & Hepatology
(16)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Adult
(12)
Female
(12)
Male
(11)
Gastroenterology. Liver. Pancreas. Abdomen
(6)
Inflammatory Bowel Disease
(6)
Life Sciences
(6)
Middle Aged
(6)
Other Diseases. Semiology
(6)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(6)
Case-Control Studies
(4)
Crohn Disease - Pathology
(4)
Crohn's Disease
(4)
Surgery
(4)
Crohns Disease
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Serum calprotectin as a biomarker for Crohn's disease

Multilocus Sequence Typing Reveals Intrafamilial Transmission and Microevolutions of Candida albicans Isolates from the Human Digestive Tract

Acute and Chronic Complications After Abdominal/Pelvic Radiation in Patients With Inflammatory Bowel Disease

2114 Chemotherapy tolerance and oncologic outcomes in patients with inflammatory bowel disease and gastrointestinal malignancy: The Mount Sinai Hospital experience

Predictive value of patient-reported outcomes to mucosal healing in patients with moderately to severely active ulcerative colitis

PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)

PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's Disease

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

European evidence-based Consensus on the management of ulcerative colitis: Current management

Multiomics Analyses to Deliver the Most Effective Treatment to Every Patient With Inflammatory Bowel Disease

Stress-induced disruption of colonic epithelial barrier: role of interferon-γ and myosin light chain kinase in mice

Preface

Preface

P386 Pharmacokinetics of laquinimod in patients with active moderate to severe Crohn's disease

PGI27 - Predictive value of patient-reported outcomes to mucosal healing in patients with moderately to severely active ulcerative colitis

DOP059 Reduction of fecal calprotectin levels and relationship to clinical parameters in the phase 2 study of laquinimod for the treatment of active moderate to severe Crohn's disease

RIP2 polymorphisms in inflammatory bowel diseases

Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease

O-10: Increase of inflammatory bowel disease incidence in teenagers in a prospective population-based study during a 21-year period (1998–2008)

DOP028 Development of red flags for early referral of adults with symptoms and signs suggestive of Crohn's disease: an IOIBD initiative

Evidence of Lymphocyte Alveolitis in Crohn's Disease

Familial expression of anti- Saccharomyces cerevisiae mannan antibodies in Crohn’s disease and ulcerative colitis: a GISC study

Suchergebnisse filtern